August 2018

Challenges & Solutions in Today’s In Vitro Transporter Research

Author: Dr. Joanna Barbara, Michael Millhollen Posted: 30 August 2018

In vitro drug transport assays are performed throughout drug development and range from simple permeability screens to kinetic assessments in complex assay formats. Sometimes interpreting transporter assay results is straightforward, and sometimes applying the data to make smart decisions is challenging...

Read more

Sekisui XenoTech Named Best Global CRO 2018; Recognised Leaders in Pharmaceutical Safety Testing 2018

Author: Michael Millhollen Posted: 24 August 2018

Sekisui XenoTech has been named the Best Global CRO and was recognized for leadership in Pharmaceutical Safety Testing in the 2018 International Lifesciences Awards...

Read more

Response to FDA Framework for Assessment of Drug-Drug Interactions for Therapeutic Proteins RFI and Comments

Author: Michael Millhollen Posted: 06 August 2018

In July, Drs. Maciej Czerwinski, Director of Consulting, and Brian Ogilvie, Vice President of Scientific Consulting, submitted Sekisui XenoTech’s comments in response to the Food and Drug Administration (FDA) public docket to assist with its development of a policy/guidance document on the assessment of drug-drug interactions (DDIs) for therapeutic proteins (TPs)...

Read more